SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-24-077644
Filing Date
2024-03-26
Accepted
2024-03-26 16:30:56
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d802487dsc13ga.htm SC 13G/A 46822
  Complete submission text file 0001193125-24-077644.txt   48535
Mailing Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003
Business Address 22 EINSTEIN ST., 4TH FLOOR NESS ZIONA L3 7414003 (972) 72 394 2377
BiomX Inc. (Subject) CIK: 0001739174 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-90744 | Film No.: 24784063
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814
Business Address 4550 MONTGOMERY STREET SUITE 1100N BETHESDA MD 20814 301-951-4422
Cystic Fibrosis Foundation (Filed by) CIK: 0001957515 (see all company filings)

IRS No.: 131930701 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A